Cervical cancer prevention in the 21st century: cost is not the only issue

Autor:	Dana Greeson, Deborah Maine, Sarah Hurlburt
Rok vydání:	2011
Předmět:	Program evaluation medicine.medical_specialty Time Factors media_common.quotation_subject Developing country Uterine Cervical Neoplasms Underserved Population medicine Screening method Humans Papillomavirus Vaccines Letters Developing Countries Early Detection of Cancer media_common Gynecology Cervical cancer business.industry Papillomavirus Infections Public Health Environmental and Occupational Health Cancer medicine.disease Family medicine Cervical cancer prevention Female business Publicity
Zdroj:	American journal of public health. 101(9)
ISSN:	1541-0048
Popis:	The wide publicity related to human papillomavirus (HPV) vaccines has led to a sense that HPV vaccine programs are inevitable in both developed and developing countries, whereas 2 existing methods of screening—visual inspection with ascetic acid (VIA) and DNA testing—have received much less attention. These screening methods detect cervical lesions better than does the Papanicolaou test and allow immediate treatment, minimizing loss to follow-up. These advantages may outweigh the strengths of HPV vaccines. Priority should be given to improving screening coverage with VIA and DNA tests, focusing on women older than 30 years and underserved populations in all countries. This approach will save the lives of millions of women who have already been exposed to HPV and will develop cervical cancer during the next 20 years.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be453188ef9af32b4a1990db1c98aade https://pubmed.ncbi.nlm.nih.gov/22515848 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.